In this study, we identified a compound SN-38, an analog of the natural compound camptothecin (CPT), potently inhibited HR repair activity and sensitize ovarian cancer cells to PARP inhibitor treatment in vitro and in vivo. The gene discussed is PARP1; the disease is ovarian cancer.